FMP

FMP

Enter

PHAT - Phathom Pharmac...

photo-url-https://images.financialmodelingprep.com/symbol/PHAT.png

Phathom Pharmaceuticals, Inc.

PHAT

NASDAQ

Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

7.45 USD

-0.37 (-4.97%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Ms. Terrie J. Curran

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

CIK

0001783183

ISIN

US71722W1071

CUSIP

71722W107

Address

100 Campus Drive

Phone

877 742 8466

Country

US

Employee

452

IPO Date

Oct 25, 2019

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

PHAT Financial Summary

CIK

0001783183

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

71722W107

ISIN

US71722W1071

Country

US

Price

7.45

Beta

0.72

Volume Avg.

1.27M

Market Cap

509.41M

Shares

-

52-Week

6.065-19.71

DCF

4.77

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.3

P/B

-

Website

https://www.phathompharma.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest PHAT News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep